Inflectra and Pyoderma - a phase IV clinical study of FDA data

Summary:

Pyoderma is reported as a side effect among people who take Inflectra (infliximab-dyyb), especially for people who are female, have been taking the drug for 1 - 2 years also take Prednisone, and have Crohn's disease.

The phase IV clinical study analyzes which people have Pyoderma when taking Inflectra. It is created by eHealthMe based on reports of 52,342 people who have side effects when taking Inflectra from the FDA, and is updated regularly.

What is Inflectra?

Inflectra has active ingredients of infliximab-dyyb. eHealthMe is studying from 52,370 Inflectra users. Check the latest studies of Inflectra.

What is Pyoderma?

Pyoderma (any skin disease that is pyogenic) is found to be associated with 65 drugs and 168 conditions by eHealthMe. Check the latest studies of Pyoderma.

On Apr, 25, 2026

52,342 people reported to have side effects when taking Inflectra.
Among them, 25 people (0.05%) have Pyoderma.

Among these 25 people:

How long have people been on Inflectra when they have Pyoderma? *

What is the gender of people who have Pyoderma when taking Inflectra? *

female: 100 %
male: 0.0 %

What are other drugs people take besides Inflectra? *

What are other side effects people have besides Pyoderma? *

Malaise (a feeling of general discomfort or uneasiness): 15 people, 60.00%
Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 12 people, 48.00%
Joint Pain: 12 people, 48.00%
Fatigue (feeling of tiredness): 11 people, 44.00%
Fever: 11 people, 44.00%
Nausea (feeling of having an urge to vomit): 9 people, 36.00%
Nausea And Vomiting: 9 people, 36.00%
Influenza Like Illness: 8 people, 32.00%
Dehydration (dryness resulting from the removal of water): 8 people, 32.00%
Weight Increased: 8 people, 32.00%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 23 people, 92.00%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 8.00%
Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 1 person, 4.00%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Inflectra and have Pyoderma?

- Check whether Pyoderma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Inflectra:

Inflectra (52,370 reports)

Pyoderma treatments and more:

Pyoderma (816 reports)

Browse all side effects of Inflectra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pyoderma:

Pyoderma (65 drugs)

Browse all the conditions that are associated with Pyoderma:

Pyoderma (168 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab-dyyb (the active ingredients of Inflectra) and Inflectra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.